Concepts (206)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplasms | 8 | 2021 | 2898 | 0.820 |
Why?
|
| B7 Antigens | 1 | 2021 | 5 | 0.800 |
Why?
|
| Cerebrospinal Fluid | 1 | 2021 | 32 | 0.790 |
Why?
|
| Mast Cells | 1 | 2021 | 92 | 0.770 |
Why?
|
| Betacoronavirus | 2 | 2020 | 258 | 0.750 |
Why?
|
| Hyponatremia | 1 | 2020 | 25 | 0.750 |
Why?
|
| Leukapheresis | 1 | 2019 | 19 | 0.690 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 316 | 0.650 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 301 | 0.650 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2019 | 196 | 0.630 |
Why?
|
| Tandem Mass Spectrometry | 4 | 2019 | 103 | 0.570 |
Why?
|
| Parasitic Diseases | 1 | 2015 | 2 | 0.540 |
Why?
|
| Hospital Information Systems | 1 | 2015 | 8 | 0.540 |
Why?
|
| Cell Proliferation | 1 | 2021 | 1578 | 0.510 |
Why?
|
| Antibodies, Monoclonal | 1 | 2021 | 1376 | 0.500 |
Why?
|
| Clostridium Infections | 1 | 2015 | 125 | 0.450 |
Why?
|
| Antineoplastic Agents | 2 | 2021 | 2360 | 0.430 |
Why?
|
| Appointments and Schedules | 1 | 2012 | 53 | 0.410 |
Why?
|
| Blood Loss, Surgical | 1 | 2012 | 112 | 0.410 |
Why?
|
| Erythrocyte Transfusion | 1 | 2012 | 60 | 0.400 |
Why?
|
| Elective Surgical Procedures | 1 | 2012 | 116 | 0.390 |
Why?
|
| Mass Screening | 1 | 2012 | 618 | 0.300 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2021 | 292 | 0.290 |
Why?
|
| Aged | 13 | 2021 | 18415 | 0.270 |
Why?
|
| Methotrexate | 2 | 2016 | 249 | 0.260 |
Why?
|
| Humans | 32 | 2022 | 86643 | 0.250 |
Why?
|
| Leukocyte Count | 3 | 2020 | 220 | 0.250 |
Why?
|
| Male | 15 | 2022 | 40965 | 0.220 |
Why?
|
| Immunosuppressive Agents | 2 | 2019 | 977 | 0.210 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2022 | 47 | 0.210 |
Why?
|
| Chromatography, High Pressure Liquid | 3 | 2019 | 315 | 0.210 |
Why?
|
| Radioimmunotherapy | 1 | 2021 | 25 | 0.190 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2021 | 78 | 0.190 |
Why?
|
| Clinical Laboratory Services | 1 | 2020 | 4 | 0.190 |
Why?
|
| Iodine Radioisotopes | 1 | 2021 | 134 | 0.190 |
Why?
|
| Blood Specimen Collection | 1 | 2020 | 27 | 0.190 |
Why?
|
| Blood Chemical Analysis | 1 | 2020 | 42 | 0.190 |
Why?
|
| Pandemics | 3 | 2021 | 740 | 0.190 |
Why?
|
| Antibodies, Neutralizing | 1 | 2020 | 112 | 0.180 |
Why?
|
| Middle Aged | 12 | 2021 | 25028 | 0.180 |
Why?
|
| Circulating Tumor DNA | 1 | 2020 | 37 | 0.180 |
Why?
|
| Neutropenia | 1 | 2020 | 215 | 0.180 |
Why?
|
| Leukocytes | 1 | 2020 | 202 | 0.180 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2020 | 136 | 0.180 |
Why?
|
| Alkylating Agents | 1 | 2019 | 32 | 0.180 |
Why?
|
| Busulfan | 1 | 2019 | 39 | 0.180 |
Why?
|
| Melphalan | 1 | 2019 | 98 | 0.170 |
Why?
|
| Guidelines as Topic | 1 | 2020 | 162 | 0.170 |
Why?
|
| Antibodies, Viral | 1 | 2020 | 293 | 0.170 |
Why?
|
| Immunoglobulin G | 1 | 2020 | 456 | 0.160 |
Why?
|
| Chromatography, Liquid | 2 | 2016 | 104 | 0.160 |
Why?
|
| False Positive Reactions | 2 | 2017 | 216 | 0.160 |
Why?
|
| Aged, 80 and over | 5 | 2021 | 6509 | 0.160 |
Why?
|
| Pregnancy Tests, Immunologic | 1 | 2017 | 1 | 0.160 |
Why?
|
| Female | 16 | 2021 | 44532 | 0.160 |
Why?
|
| Chorionic Gonadotropin, beta Subunit, Human | 1 | 2017 | 8 | 0.160 |
Why?
|
| Hematologic Neoplasms | 1 | 2021 | 329 | 0.160 |
Why?
|
| Adult | 8 | 2021 | 25648 | 0.160 |
Why?
|
| Chyle | 1 | 2017 | 5 | 0.150 |
Why?
|
| Hypoalbuminemia | 1 | 2017 | 9 | 0.150 |
Why?
|
| Regression Analysis | 1 | 2019 | 596 | 0.150 |
Why?
|
| Remission, Spontaneous | 1 | 2017 | 53 | 0.150 |
Why?
|
| MicroRNAs | 1 | 2022 | 534 | 0.150 |
Why?
|
| Neuroblastoma | 1 | 2021 | 374 | 0.150 |
Why?
|
| Polymerase Chain Reaction | 3 | 2016 | 927 | 0.150 |
Why?
|
| Child | 4 | 2021 | 6927 | 0.140 |
Why?
|
| Estradiol | 1 | 2017 | 252 | 0.140 |
Why?
|
| Biomarkers, Tumor | 3 | 2022 | 1464 | 0.130 |
Why?
|
| Parasite Egg Count | 1 | 2015 | 6 | 0.130 |
Why?
|
| Toxoplasmosis | 1 | 2016 | 64 | 0.130 |
Why?
|
| Immunotherapy | 1 | 2021 | 629 | 0.130 |
Why?
|
| Testosterone | 1 | 2017 | 271 | 0.130 |
Why?
|
| Toxoplasma | 1 | 2016 | 108 | 0.130 |
Why?
|
| Blood Cell Count | 1 | 2015 | 79 | 0.130 |
Why?
|
| Acidosis, Lactic | 1 | 2014 | 12 | 0.130 |
Why?
|
| Reticulocytes | 1 | 2014 | 25 | 0.130 |
Why?
|
| Stem Cell Transplantation | 1 | 2016 | 183 | 0.130 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2015 | 62 | 0.130 |
Why?
|
| Peripheral Blood Stem Cell Transplantation | 1 | 2015 | 67 | 0.130 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2014 | 19 | 0.130 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2014 | 41 | 0.120 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2021 | 878 | 0.120 |
Why?
|
| Immunocompromised Host | 1 | 2015 | 140 | 0.120 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2020 | 455 | 0.120 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2016 | 236 | 0.120 |
Why?
|
| Hemoglobins | 1 | 2014 | 179 | 0.120 |
Why?
|
| Iron | 1 | 2014 | 164 | 0.120 |
Why?
|
| Young Adult | 4 | 2019 | 5976 | 0.120 |
Why?
|
| Biomarkers | 1 | 2020 | 1718 | 0.120 |
Why?
|
| Brain Diseases | 1 | 2014 | 180 | 0.120 |
Why?
|
| Pre-Exposure Prophylaxis | 1 | 2016 | 137 | 0.120 |
Why?
|
| Reproducibility of Results | 5 | 2020 | 2705 | 0.110 |
Why?
|
| Calcium | 1 | 2017 | 1156 | 0.110 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2014 | 375 | 0.100 |
Why?
|
| Retrospective Studies | 4 | 2021 | 8489 | 0.090 |
Why?
|
| Vaccination | 2 | 2021 | 254 | 0.090 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2014 | 1313 | 0.080 |
Why?
|
| Infant | 3 | 2021 | 3046 | 0.070 |
Why?
|
| Limit of Detection | 2 | 2017 | 20 | 0.070 |
Why?
|
| Colorectal Neoplasms | 1 | 2014 | 938 | 0.070 |
Why?
|
| Child, Preschool | 3 | 2021 | 3612 | 0.070 |
Why?
|
| Adolescent | 5 | 2021 | 8981 | 0.070 |
Why?
|
| Severity of Illness Index | 2 | 2021 | 1801 | 0.070 |
Why?
|
| Myocardial Infarction | 2 | 1999 | 376 | 0.050 |
Why?
|
| Antimetabolites | 1 | 2021 | 24 | 0.050 |
Why?
|
| Rheumatoid Factor | 1 | 2001 | 24 | 0.050 |
Why?
|
| Testicular Neoplasms | 1 | 2022 | 105 | 0.050 |
Why?
|
| Immunity, Humoral | 1 | 2021 | 67 | 0.050 |
Why?
|
| Nucleocapsid Proteins | 1 | 2020 | 10 | 0.050 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2021 | 262 | 0.050 |
Why?
|
| ROC Curve | 3 | 2015 | 752 | 0.050 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2021 | 182 | 0.050 |
Why?
|
| Fecal Microbiota Transplantation | 1 | 2020 | 62 | 0.050 |
Why?
|
| Quality Control | 1 | 2020 | 117 | 0.050 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2002 | 134 | 0.050 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2021 | 170 | 0.050 |
Why?
|
| Immunity, Cellular | 1 | 2020 | 177 | 0.040 |
Why?
|
| Mutation | 2 | 2021 | 3968 | 0.040 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2001 | 166 | 0.040 |
Why?
|
| Monocytes | 1 | 2020 | 214 | 0.040 |
Why?
|
| RNA, Viral | 1 | 2020 | 327 | 0.040 |
Why?
|
| Operating Rooms | 1 | 2020 | 126 | 0.040 |
Why?
|
| Neutrophils | 1 | 2020 | 307 | 0.040 |
Why?
|
| Phosphoproteins | 1 | 2020 | 254 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2020 | 361 | 0.040 |
Why?
|
| Troponin I | 1 | 1999 | 27 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2020 | 526 | 0.040 |
Why?
|
| Lymphocytes | 1 | 2020 | 464 | 0.040 |
Why?
|
| Immunoenzyme Techniques | 1 | 1999 | 303 | 0.040 |
Why?
|
| Sensitivity and Specificity | 3 | 2014 | 1991 | 0.040 |
Why?
|
| Wuchereria bancrofti | 1 | 2017 | 2 | 0.040 |
Why?
|
| Elephantiasis, Filarial | 1 | 2017 | 3 | 0.040 |
Why?
|
| Hexanes | 1 | 2017 | 1 | 0.040 |
Why?
|
| Acetates | 1 | 2017 | 66 | 0.040 |
Why?
|
| Urine | 1 | 2017 | 90 | 0.040 |
Why?
|
| Parasitemia | 1 | 2016 | 6 | 0.040 |
Why?
|
| Protein Binding | 1 | 2020 | 1456 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2021 | 2767 | 0.040 |
Why?
|
| New York City | 1 | 2016 | 59 | 0.040 |
Why?
|
| Quality Improvement | 1 | 2020 | 428 | 0.040 |
Why?
|
| Epidemiological Monitoring | 1 | 2016 | 39 | 0.040 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2016 | 24 | 0.030 |
Why?
|
| Age Factors | 1 | 2020 | 1851 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2016 | 131 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2021 | 2379 | 0.030 |
Why?
|
| Blood Component Removal | 1 | 2015 | 24 | 0.030 |
Why?
|
| Cell Size | 1 | 2015 | 65 | 0.030 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2015 | 50 | 0.030 |
Why?
|
| Drug Monitoring | 1 | 2016 | 118 | 0.030 |
Why?
|
| Herpesviridae | 1 | 1994 | 14 | 0.030 |
Why?
|
| Sarcoma, Kaposi | 1 | 1994 | 19 | 0.030 |
Why?
|
| Transferrin | 1 | 2014 | 19 | 0.030 |
Why?
|
| Erythrocyte Indices | 1 | 2014 | 10 | 0.030 |
Why?
|
| Cytoplasmic Granules | 1 | 2015 | 94 | 0.030 |
Why?
|
| Transplant Recipients | 1 | 2016 | 122 | 0.030 |
Why?
|
| Automation | 1 | 2015 | 106 | 0.030 |
Why?
|
| Ferritins | 1 | 2014 | 29 | 0.030 |
Why?
|
| Antigens, CD34 | 1 | 2015 | 158 | 0.030 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1994 | 78 | 0.030 |
Why?
|
| Heart-Assist Devices | 1 | 2002 | 731 | 0.030 |
Why?
|
| DNA, Viral | 1 | 1994 | 265 | 0.030 |
Why?
|
| Equipment Design | 1 | 2015 | 406 | 0.030 |
Why?
|
| DNA | 1 | 2019 | 1294 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2015 | 679 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 1673 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2015 | 579 | 0.030 |
Why?
|
| Risk Factors | 2 | 2021 | 5417 | 0.030 |
Why?
|
| Heparin | 1 | 1992 | 175 | 0.020 |
Why?
|
| Tissue Plasminogen Activator | 1 | 1992 | 162 | 0.020 |
Why?
|
| Pregnancy | 1 | 2017 | 2894 | 0.020 |
Why?
|
| Thrombolytic Therapy | 1 | 1992 | 220 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2014 | 1939 | 0.020 |
Why?
|
| Cerebral Hemorrhage | 1 | 1992 | 325 | 0.020 |
Why?
|
| Prognosis | 1 | 2014 | 3679 | 0.020 |
Why?
|
| Spectrophotometry, Infrared | 1 | 2001 | 18 | 0.010 |
Why?
|
| Data Display | 1 | 2001 | 24 | 0.010 |
Why?
|
| Discriminant Analysis | 1 | 2001 | 66 | 0.010 |
Why?
|
| Blood Transfusion | 1 | 2002 | 157 | 0.010 |
Why?
|
| Myocardial Ischemia | 1 | 2002 | 162 | 0.010 |
Why?
|
| Coronary Artery Bypass | 1 | 2002 | 228 | 0.010 |
Why?
|
| Reference Values | 1 | 2001 | 674 | 0.010 |
Why?
|
| Pattern Recognition, Automated | 1 | 2001 | 217 | 0.010 |
Why?
|
| Cardiomyopathies | 1 | 2002 | 240 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2001 | 751 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1999 | 274 | 0.010 |
Why?
|
| Length of Stay | 1 | 2002 | 702 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2002 | 710 | 0.010 |
Why?
|
| Animals | 1 | 2017 | 26582 | 0.010 |
Why?
|
| Herpesvirus 2, Saimiriine | 1 | 1994 | 1 | 0.010 |
Why?
|
| Base Composition | 1 | 1994 | 35 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1994 | 129 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1994 | 245 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 1994 | 117 | 0.010 |
Why?
|
| Herpesvirus 4, Human | 1 | 1994 | 114 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1994 | 416 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1994 | 646 | 0.010 |
Why?
|
| Partial Thromboplastin Time | 1 | 1992 | 18 | 0.010 |
Why?
|
| Hematoma, Subdural | 1 | 1992 | 23 | 0.010 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 1992 | 28 | 0.010 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 1992 | 134 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1994 | 2062 | 0.010 |
Why?
|
| Base Sequence | 1 | 1994 | 2330 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1992 | 1014 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1994 | 3030 | 0.010 |
Why?
|
| Survival Rate | 1 | 1992 | 1863 | 0.000 |
Why?
|
| Hypertension | 1 | 1992 | 1141 | 0.000 |
Why?
|